// App-Quantinova.ai

: SABA use increase weeks before asthma exacerbations recorded via a digital inhaler

Researchers

Presenter

  • Mark Levy

Principal Investigators

  • Guilherme Safioti

  • Michael Reich

  • Randall Brown

  • Michael Depietro

Medical Centers

  • Teva Pharmaceuticals, Amsterdam, Netherlands,

  • Retired General Practitioner, London, United Kingdom,

  • Teva Branded Pharmaceutical Products R&D Inc., West Chester, PA, United States of America

  • Teva Pharmaceutical Industries, Ltd., Frazer, PA

Locations

  • Israel

  • United States

  • United Kingdom

  • Netherlands

Companies

  • N/A

Study Components

Therapeutic Area

  • Autoimmune (AI)

Disease

  • Asthma

Biomarkers

  • N/A

Drug/Treatment

  • Salbutamol

Outcome

  • N/A

Study Design

  • Open Label

  • Controlled

Phase

  • N/A

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved